Swiss National Bank Reata Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$79.22 - $105.37 $459,476 - $611,146	-5,800 Reduced 9.97%	52,400 $5.34 Million
Q1 2023 May 10, 2023	SELL	$30.85 - $93.17 $203,610 - $614,922	-6,600 Reduced 10.19%	58,200 $5.29 Million
Q4 2022 Feb 08, 2023	BUY	$22.15 - $42.11 $33,225 - $63,165	1,500 Added 2.37%	64,800 $2.46 Million
Q1 2022 May 09, 2022	BUY	$24.12 - $39.6 $106,128 - $174,240	4,400 Added 7.47%	63,300 $2.07 Million
Q3 2021 Nov 08, 2021	BUY	$100.0 - $143.02 $70,000 - $100,114	700 Added 1.2%	58,900 $5.93 Million
Q2 2021 Aug 06, 2021	BUY	$78.27 - $151.29 $172,194 - $332,838	2,200 Added 3.93%	58,200 $8.24 Million
Q1 2021 May 07, 2021	BUY	$94.25 - $132.81 $103,675 - $146,091	1,100 Added 2.0%	56,000 $5.58 Million
Q4 2020 Feb 05, 2021	BUY	$102.03 - $184.62 $61,218 - $110,772	600 Added 1.1%	54,900 $6.79 Million
Q3 2020 Nov 09, 2020	BUY	$93.53 - $163.34 $121,589 - $212,342	1,300 Added 2.45%	54,300 $5.29 Million
Q2 2020 Aug 05, 2020	BUY	$126.3 - $176.56 $1.38 Million - $1.92 Million	10,900 Added 25.89%	53,000 $8.27 Million
Q1 2020 May 08, 2020	BUY	$124.16 - $247.74 $571,136 - $1.14 Million	4,600 Added 12.27%	42,100 $6.08 Million
Q4 2019 Feb 06, 2020	BUY	$74.57 - $217.92 $59,655 - $174,336	800 Added 2.18%	37,500 $7.67 Million
Q3 2019 Nov 12, 2019	BUY	$71.26 - $95.75 $64,134 - $86,175	900 Added 2.51%	36,700 $2.95 Million
Q2 2019 Aug 02, 2019	BUY	$77.72 - $94.35 $62,176 - $75,480	800 Added 2.29%	35,800 $3.38 Million
Q1 2019 May 10, 2019	BUY	$51.9 - $101.79 $72,660 - $142,506	1,400 Added 4.17%	35,000 $2.99 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $19,504 - $30,576	400 Added 1.2%	33,600 $1.89 Million
Q3 2018 Nov 08, 2018	BUY	$35.64 - $92.06 $260,172 - $672,038	7,300 Added 28.19%	33,200 $2.71 Million
Q2 2018 Aug 09, 2018	BUY	$19.94 - $40.96 $119,640 - $245,760	6,000 Added 30.15%	25,900 $906,000
Q3 2017 Nov 03, 2017	BUY	$26.29 - $31.88 $523,171 - $634,412	19,900	19,900 $619,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account